You are here: Industry Insights > Diabetes

News List

2001 to 2017 Saw Increase in Prevalence of T1DM, T2DM in Youth drugs
August 25, 2021
From 2001 to 2017, there was an increase in the estimated prevalence of type 1 and type 2 diabetes in youth in the United States, according to a study published in the Aug. 24/31 issue of the Journal of the American Medical Association.
Dangerous Diabetes Tied to Pregnancy Is on the Rise drugs
August 19, 2021
Growing numbers of pregnant women are developing gestational diabetes, putting them and their babies at risk for complications later on.
Diabetes treatment lowers PromarkerD risk score for diabetic kidney disease prnasia
August 13, 2021
Treatment with diabetes drug canagliflozin lowers the PromarkerD risk score for developing diabetic kidney disease in patients with type 2 diabetes, latest research suggests.
FDA approves first interchangeable biosimilar insulin product europeanpharmaceuticalreview
July 30, 2021
The first interchangeable biosimilar insulin product will help increase access and affordability of insulin for diabetics.
FDA Approves Biosimilar Interchangeable Insulin Treatment for Diabetes americanpharmaceuticalreview
July 30, 2021
The FDA approved the first interchangeable biosimilar product, Mylan’s Semglee (insulin glargine-yfgn). Semglee (insulin glargine-yfgn) is both biosimilar to and interchangeable with Lantus (insulin glargine).
FDA Approves First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes fda.gov
July 29, 2021
Today, the U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus.
Innovation Zed and SocialDiabetes Announce Global Partnership to Improve Health Outcomes for People With Diabetes prnasia
July 15, 2021
Innovation Zed Ltd., the developer of novel Insulin Pen "InsulCheck CONNECT" add-on device, and SocialDiabetes, a leading diabetes management company, today announced the signing of a global partnership and data integration agreement.
AHA News: The Challenge of Diabetes in the Black Community Needs Comprehensive Solutions drugs
July 14, 2021
One thing is clear about the serious problem of diabetes among Black people in the United States: It's not just one thing causing the problem.
FDA declines to approve Provention Bio’s teplizumab for diabetes pharmaceutical-technology
July 08, 2021
The US Food and Drug Administration (FDA) has declined to approve Provention Bio’s biologics licence application (BLA) for teplizumab in type 1 diabetes (T1D), an autoimmune disease.
Ildong Pharmaceutical starts Phase 1 study of new diabetes therapy in Germany prnasia
July 02, 2021
A Phase 1 study on new drug candidate IDG16177 of novel oral treatment for type 2 diabetes, which is being developed by Ildong Pharmaceutical, is initiated in Germany.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 37 38 Next page